SCHEMBL4586377

SCHEMBL4586377

CCCCCCCCCCCCOc1ccc(C=Cc2ccc(C=O)cc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.61
▸ LMNA P02545 1/20 0.61
▸ MAPT P10636 1/20 0.61
▸ HPGD P15428 1/20 0.61
▸ SMN1; SMN2 Q16637 1/20 0.61
▸ AHR P35869 1/20 0.58
▸ NR5A1 Q13285 1/20 0.54
▸ TP53 P04637 1/20 0.53
▸ TSHR P16473 1/20 0.53
▸ PLA2G4B P0C869 1/20 0.51
▸ CHRNA7 P36544 2/20 0.51
▸ CHRNA10 Q9GZZ6 2/20 0.51
▸ CHRNA9 Q9UGM1 2/20 0.51
▸ MAOA P21397 2/20 0.51
▸ MAOB P27338 2/20 0.51
▸ APP P05067 5/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13863195 1.00 ALDH1A1 (0.61) ALDH1A1LMNAMAPTHPGDSMN1; SMN2
SCHEMBL6478313 1.00 ALDH1A1 (0.61) ALDH1A1LMNAMAPTHPGDSMN1; SMN2
SCHEMBL3066497 0.95 ALDH1A1 (0.67) ALDH1A1LMNAMAPTHPGDSMN1; SMN2
SCHEMBL1164661 0.95 ALDH1A1 (0.67) ALDH1A1LMNAMAPTHPGDSMN1; SMN2
SCHEMBL1958537 0.95 ALDH1A1 (0.67) ALDH1A1LMNAMAPTHPGDSMN1; SMN2
SCHEMBL1164373 0.95 ALDH1A1 (0.67) ALDH1A1LMNAMAPTHPGDSMN1; SMN2
SCHEMBL585375 0.95 ALDH1A1 (0.67) ALDH1A1LMNAMAPTHPGDSMN1; SMN2
SCHEMBL1864244 0.95 ALDH1A1 (0.67) ALDH1A1LMNAMAPTHPGDSMN1; SMN2
SCHEMBL10498828 0.95 ALDH1A1 (0.67) ALDH1A1LMNAMAPTHPGDSMN1; SMN2
SCHEMBL10498196 0.95 ALDH1A1 (0.67) ALDH1A1LMNAMAPTHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8039832-B2 Liquid crystalline organic semiconductor material, and semiconductor element or information recording medium using the same YAMANASHI UNIVERSITY (JP) 2011-10-18 — — US disclosed
US-20090250676-A1 LIQUID CRYSTALLINE ORGANIC SEMICONDUCTOR MATERIAL, AND SEMICONDUCTOR ELEMENT OR INFORMATION RECORDING MEDIUM USING THE SAME YAMANASHI UNIVERSITY (JP) 2009-10-08 — — US disclosed
US-7371887-B2 Oligo(p-phenylene vinylene) amphiphiles and methods for self-assembly NORTHWESTERN UNIVERSITY (US) 2008-05-13 — — US disclosed
US-20050214952-A1 Oligo(p-phenylene vinylene) amphiphiles and methods for self-assembly ENGERY, UNITED STATES DEPARTMENT OF 2005-09-29 — — US disclosed
WO-2005056499-A2 OLIGO(P-PHENYLENE VINYLENE) AMPHIPHILES AND METHODS FOR SELF-ASSEMBLY NORTHWESTERN UNIVERSITY (US) 2005-06-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050214952-A1 Oligo(p-phenylene vinylene) amphiphiles and methods for self-assembly PHOSPHO1, VCL, PCBP1 ALDH1A1 4330/4885LMNA 1050/4885MAPT 2161/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback